(2023). Consultation Rate and Mode by Deprivation in English General Practice From 2018 to 2022: Population-Based Study. Jmir Public Health Surveill, 9, e44944. http://doi.org/10.2196/44944
. Covid-19
(2023). The impact of the COVID-19 pandemic on referrals to musculoskeletal services from primary care and subsequent incidence of inflammatory rheumatic musculoskeletal disease: an observational study. Rheumatol Adv Pract, 7, rkad044. http://doi.org/10.1093/rap/rkad044
. (2023). Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study. Eclinicalmedicine, 58, 101932. http://doi.org/10.1016/j.eclinm.2023.101932
. (2023). Impact of the COVID-19 pandemic on incidence of tics in children and young people: a population-based cohort study. Eclinicalmedicine, 57, 101857. http://doi.org/10.1016/j.eclinm.2023.101857
. (2022). COVID-19 ethnic inequalities in mental health and multimorbidities: protocol for the COVEIMM study. Soc Psychiatry Psychiatr Epidemiol, 1-11. http://doi.org/10.1007/s00127-022-02305-y
. (2022). Migrants' primary care utilisation before and during the COVID-19 pandemic in England: An interrupted time series analysis. Lancet Reg Health Eur, 20, 100455. http://doi.org/10.1016/j.lanepe.2022.100455
. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
. (2022). Mortality of Care Home Residents and Community-Dwelling Controls During the COVID-19 Pandemic in 2020: Matched Cohort Study. J Am Med Dir Assoc, 23, 923-929.e2. http://doi.org/10.1016/j.jamda.2022.04.003
. (2022). Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries. Pharmacoepidemiol Drug Saf, 31, 495-510. http://doi.org/10.1002/pds.5419
. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413
.